The Start Center for Cancer Care

San Antonio, Texas 78229

1 studies enrolling now · 21 studies all time

What they study most

Advanced Breast Cancer, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Tumors or Hematologic Malignancies, Bladder Cancer, Breast Cancer, Breast Cancer (HR+HER2-), Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Clear-Cell Renal-Cell Carcinoma (ccRCC)

Studies at this site

• A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body — Recruiting now
• Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer — Stopped early
• Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab — Running, not enrolling
• COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies — Completed
• S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers — Completed
• COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. — Completed
• A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors — Completed
• COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. — Completed
• Study of ADCT-301 in Patients With Selected Advanced Solid Tumors — Stopped early
• A Study of LY3321367 Alone or With LY3300054 in Participants With Advanced Relapsed/Refractory Solid Tumors — Completed
• ASCO Survey on COVID-19 in Oncology (ASCO) Registry — Status unconfirmed
• APG-1387 in Patients With Advanced Solid Tumors or Hematologic Malignancies — Completed
• APG-115 in Patients With Advanced Solid Tumors or Lymphomas — Completed
• A Study of APG-1252 in Patients With SCLC or Other Solid Tumors — Completed
• A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors — Status unconfirmed
• Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors — Completed
• Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors — Completed
• A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors — Completed
• A Study of LY3076226 in Participants With Advanced or Metastatic Cancer — Completed
• A Study of LY3164530 in Participants With Cancer — Completed
• Multi-Institutional Registry for Prostate Cancer Radiosurgery — Status unconfirmed